Marks Gilbert Lynn (CIK 1916940) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-10). Recent activity: Buy ANTX (3,775 shares), Buy ANTX (11,560 shares), Buy ANTX (10,367 shares), Buy ANTX (11,875 shares), Buy ANTX (9,705 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-10 | AN2 Therapeutics, Inc. (ANTX) | Director | Buy | 3,775 | $0 |
| 2026-01-14 | AN2 Therapeutics, Inc. (ANTX) | Director | Buy | 11,560 | $0 |
| 2025-10-14 | AN2 Therapeutics, Inc. (ANTX) | Director | Buy | 10,367 | $0 |
| 2025-07-11 | AN2 Therapeutics, Inc. (ANTX) | Director | Buy | 11,875 | $0 |
| 2025-04-11 | AN2 Therapeutics, Inc. (ANTX) | Director | Buy | 9,705 | $0 |
Source: SEC Form 4 filings · as of 2026-04-10